[Lipohypertrophy].
Müssig
Karsten
K
Medizinische Klinik IV, Universitätsklinikum Tübingen. Karsten.Muessig@med.uni-tuebingen.de
Gallwitz
Baptist
B
D050153:Abdominal Fat / Q000187:drug effects / Q000473:pathology*; D000368:Aged; D001170:Arthritis, Infectious / Q000150:complications; D002921:Cicatrix / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003937:Diagnosis, Differential; D006801:Humans; D006984:Hypertrophy / Q000175:diagnosis / Q000209:etiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007279:Injections, Subcutaneous / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009336:Necrosis; D010019:Osteomyelitis / Q000150:complications
D007004:Hypoglycemic Agents; D007328:Insulin